Science & Health

Guillain-Barre Syndrome (GBS)

Pune tightens RO regulations amid rising GBS cases

In response to the escalating Guillain-Barre Syndrome (GBS) crisis, which has claimed nine lives in Pune city since its outbreak on January 5, the Pune Municipal Corporation (PMC) has issued stringent regulations for private reverse osmosis (RO) projects within its jurisdiction. The move comes after a 34-year-old man from Wagholi succumbed to the disease at Sassoon General Hospital, marking the ninth GBS fatality in the city. Feb 18, 2025
Govt to exempt three more cancer drugs from customs duty

Alcohol-related cancers on rise in India, say experts

Alcohol-related cancers are a growing concern in India, said health experts on Monday, even as the World Health Organization (WHO) recently called for prominent health warning labels on alcoholic beverages. Feb 17, 2025
GBS outbreak: Mumbai reports first death

Mumbai records first GBS-related death: City's healthcare system on alert

Mumbai, the bustling metropolis of India, has reported its first death due to Guillain-Barre Syndrome (GBS), a rare neurological disorder. The deceased, a 53-year-old man from Wadala, was employed as a ward attendant at the Brihan Mumbai Municipal Corporation's VN Desai Hospital. His demise marks the first GBS-related fatality in the city. Feb 12, 2025
CDSCO grants license to India's 1st vaccine for cattle, buffalo

India's first vaccine against lumpy skin disease gets CDSCO nod; boon for vet healthcare

The Central Drug Standards Control Organization (CDSCO) has granted approval to Biolumpivaxin, India's first vaccine against lumpy skin disease (LSD) in dairy cattle and buffaloes. Developed by Biovet, a Bharat Biotech group company, this novel indigenous live-attenuated marker vaccine is set to revolutionize veterinary healthcare in India. Feb 10, 2025
Prev 3 4 5 6 7 8 9 10 11 12 Next